Position in JNJ
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$9,232,570
+$323,466 QoQ
Shares Held
36,353
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.20%
of 13F equity value
Holder Rank
#1,162
of 4,664 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Field & Main Bank holds $26,958,516 across 8 Drug Manufacturers - General names. JNJ ranks #2 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,859 | $9,426,320 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
36,353 | $9,232,570 | |
| 3 | ABBV |
AbbVie Inc.
|
10,715 | $2,696,322 | |
| 4 | AMGN |
Amgen Inc
|
7,076 | $2,562,361 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,053 | $2,448,310 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,151 | $527,280 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
300 | $37,902 | |
| 8 | PFE |
Pfizer Inc
|
1,140 | $27,451 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,232,570 | 36,353 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $8,909,104 | 36,447 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $7,756,899 | 37,482 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $7,135,147 | 38,481 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $5,916,923 | 38,736 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $6,451,341 | 38,901 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $5,618,631 | 38,851 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,223,265 | 38,401 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,623,798 | 38,477 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $6,044,914 | 38,213 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $6,018,345 | 38,397 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $5,993,727 | 38,483 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,612,805 | 21,827 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $3,415,425 | 22,035 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $3,884,709 | 21,991 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $3,621,037 | 22,166 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $3,983,324 | 22,440 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $3,925,467 | 22,149 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,825,809 | 22,364 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,610,978 | 22,359 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $3,873,696 | 23,514 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,634,600 | 22,115 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,469,442 | 22,045 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $3,405,332 | 22,873 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $3,188,644 | 22,674 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||